Related Experiment Video
Updated: Feb 9, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma
Nicole E Rich1, Caitlin Hester2, Mobolaji Odewole1
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Parkland Health and Hospital System, Dallas, Texas.
Insights
Racial and ethnic minorities face worse outcomes for hepatocellular carcinoma (HCC). Disparities in early tumor detection and access to curative treatment contribute to these differences in HCC survival.
Area of Science:
- Hepatocellular Carcinoma (HCC) Research
- Health Disparities
- Oncology Outcomes
Background:
- Racial and ethnic minorities exhibit higher mortality rates for hepatocellular carcinoma (HCC) compared to non-Hispanic whites.
- Existing research lacks clarity on whether tumor characteristics or liver dysfunction explain these disparities.
- This study aimed to investigate racial and ethnic variations in HCC presentation, treatment, and survival outcomes.
Purpose of the Study:
- To characterize racial and ethnic differences in the presentation of hepatocellular carcinoma (HCC).
- To analyze disparities in treatment receipt for HCC among different racial and ethnic groups.
- To evaluate the impact of race and ethnicity on overall survival in HCC patients.
Main Methods:
- Retrospective analysis of 1117 patients diagnosed with HCC between January 2008 and July 2017.
- Utilized multivariable logistic regression and Cox proportional hazard models.
- Identified factors associated with curative therapy receipt and overall survival.
Main Results:
- Hispanic and black patients were less likely to be diagnosed with early-stage HCC compared to white patients.
- Among those with early-stage HCC, Hispanic patients were significantly less likely to receive curative treatment.
- Black and Hispanic patients experienced shorter median survival times, with black patients showing significantly higher mortality post-adjustment.
Conclusions:
- Racial and ethnic disparities in HCC outcomes are linked to differences in early tumor detection and the utilization of curative treatments.
- Addressing these disparities in early detection and treatment access is crucial for improving patient outcomes.
- Intervention strategies targeting early diagnosis and treatment receipt can help reduce HCC outcome disparities.
Background & Aims:
Racial and ethnic minorities are reported to have higher mortality related to hepatocellular carcinoma (HCC) than non-Hispanic whites. However, it is not clear whether differences in tumor characteristics or liver dysfunction among racial or ethnic groups affect characterization of causes for this disparity. We aimed to characterize racial and ethnic differences in HCC presentation, treatment, and survival.
Methods:
We performed a retrospective study of patients diagnosed with HCC from January 2008 through July 2017 at 2 large health systems in the United States. We used multivariable logistic regression and Cox proportional hazard models to identify factors associated with receipt of curative therapy and overall survival.
Results:
Among 1117 patients with HCC (35.9% white, 34.3% black, 29.7% Hispanic), 463 (41.5%) were diagnosed with early stage HCC (Barcelona Clinic Liver Cancer stage 0/A) and 322 (28.8%) underwent curative treatment. Hispanic (odds ratio [OR], 0.75; 95% CI, 0.55-1.00) and black patients (OR, 0.74; 95% CI, 0.56-0.98) were less likely to be diagnosed with early stage HCC than white patients. Among patients with early stage HCC, Hispanics were less likely to undergo curative treatment than whites (OR, 0.58; 95% CI, 0.36-0.91). Black patients with early stage HCC were also less likely to undergo curative treatment than white patients, but this difference was not statistically significant (OR, 0.66; 95% CI, 0.43-1.03). Black and Hispanic patients had shorter median survival times than white patients (10.6 and 14.4 mo vs 16.3 mo). After adjusting for type of medical insurance, Child-Pugh class, Barcelona Clinic Liver Cancer stage, and receipt of HCC treatment, black patients had significantly higher mortality (hazard ratio, 1.12; 95% CI, 1.10-1.14) and Hispanic patients had lower mortality (hazard ratio, 0.83; 95% CI, 0.74-0.94) than white patients.
Conclusions:
In a retrospective study of patients diagnosed with HCC, we found racial/ethnic differences in outcomes of HCC to be associated with differences in detection of tumors at early stages and receipt of curative treatment. These factors are intervention targets for improving patient outcomes and reducing disparities.
Related Concept Videos
Self-Presentation
Self-Presentation: Self-Monitoring and Self-Handicapping
Strategies of Self-Presentation I: Strategic Self-Presentation
Processes of Self-Presentation
Ethnic Identity within a Larger Culture
Predicting Reaction Outcomes

